Send me a link:

*Text messaging rates may apply.

 Dow Down 0.42% Nasdaq Down 0.39%

Enzo Biochem Inc. (ENZ)

-NYSE
4.61 Down 0.19(3.96%) 4:05PM EDT
Prev Close:4.80
Open:4.82
Bid:3.76 x 100
Ask:5.74 x 5400
1y Target Est:5.50
Beta:1.82
Earnings Date:Oct 13 - Oct 17 (Est.)
Day's Range:4.52 - 4.86
52wk Range:2.16 - 5.53
Volume:267,754
Avg Vol (3m):320,119
Market Cap:202.04M
P/E (ttm):N/A
EPS (ttm):-0.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ENZ

Comparison

Symbol% ChgMkt Cap
ENZDown 3.96%202.04M
BRLIUp 1.18%880.26M
DGXDown 0.21%8.78B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.23
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jul-14) :-0.27
Quarterly EPS Est (Jul-14) :-0.07
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Enzo Biochem, Inc., an integrated life sciences and biotechnology company, is engaged in the research, development, manufacture, and marketing of diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback